Adjunctive Use Of A Novel Hyaluronic Acid/Chlorhexidine Gel In The Non Surgical Treatment Of Periodontitis
1 other identifier
interventional
20
1 country
1
Brief Summary
General Objective : To evaluate the outcome of non surgical periodontal therapy with local drug delivery adjunct to scaling and root planning Specific Objective : To determine the effect of intra-pocket application of hyaluronic acid /chlorohexidine gel in non surgical periodontal treatment on clinical periodontal parameters and microbiological level .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 28, 2022
CompletedFirst Posted
Study publicly available on registry
January 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2024
CompletedJanuary 12, 2023
January 1, 2023
1.2 years
December 28, 2022
January 10, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
pocket depth
2 months
Bleeding on Probing
2 months
Clinical attachment level
2 months
Secondary Outcomes (1)
Plaque index
2 months
Study Arms (2)
Test
EXPERIMENTALNS therapy + Chlorhexidine/Hyaluronic acid subgingival gel application
Control
PLACEBO COMPARATORNS therapy + Placebo gel subgingival application
Interventions
Subgingival ultrasonic debridement + manual root planning
Eligibility Criteria
You may qualify if:
- Age : 20-60 years old
- At least 20 remaining teeth
- Periodontitis stage III and IV ,Grade A, B and C
You may not qualify if:
- Patients taking specific medications: antibiotic , anticoagulants or anti-inflammatory
- Previous periodontal therapy in the past 3-6 months.
- Immunocompromised patients
- Systemically diseased patients: Diabetes ,osteoporosis etc
- History of allergies or hypersensitivity reactions to chlorohexidine or Hyaluronic acid
- Pregnant or lactating women.
- Heavy Smokers (more than 20/day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Dental Hospital Sharjah
Sharjah city, United Arab Emirates
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zahi BADRAN, Phd
University of Sharjah
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 28, 2022
First Posted
January 12, 2023
Study Start
October 1, 2022
Primary Completion
December 20, 2023
Study Completion
June 20, 2024
Last Updated
January 12, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share